Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclophosphamide in TP53-mutated Metastatic Colorectal Cancer
NCT03149679Phase 2Terminated
- Sponsor
- Haukeland University Hospital
- Start
- May 2017
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in colorectal cancer (metastatic) (mCRC), sponsored by Haukeland University Hospital. Started May 2017; status: terminated.
02
Drugs
cyclophosphamide
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT03149679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03149679.